Identification
- Composition (DCI)
- lévosimendan
- Manufacturer
- AFRIC-PHAR
- ATC code
- C01CX08
- Presentation
- Flacon de 5 ml
- Schedule / Reimb.
- A
- Hospital price
- 7811.00 MAD
Indications
Indiqué chez l'adulte dans le traitement à court terme de l’insuffisance cardiaque chronique sévère en décompensation aiguë (ICDA) lorsque le traitement habituel est insuffisant et lorsque l’utilisation d’un agent inotrope est approprié.
Find an open pharmacy
On-call pharmacies near you
About SIMDAX 2.25 MG / ML
SIMDAX 2.25 MG / ML is marketed in Morocco by AFRIC-PHAR and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of SIMDAX 2.25 MG / ML, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about SIMDAX 2.25 MG / ML
Answers to common questions from Moroccan patients about this drug.